Reliability of self‐report versus the capacity to consent to treatment instrument to make medical decisions in brain metastasis and other metastatic cancers
Abstract Objective To evaluate the ability of persons with metastatic cancer to self‐assess their medical decision‐making capacity (MDC). To investigate this, we compared an objective measure of MDC with self‐ratings and evaluated predictors of agreement. Methods Data were obtained from a cross‐sect...
Guardado en:
Autores principales: | , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3a448e66da164c43831ad3380f57fd9a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:3a448e66da164c43831ad3380f57fd9a |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:3a448e66da164c43831ad3380f57fd9a2021-11-25T06:06:36ZReliability of self‐report versus the capacity to consent to treatment instrument to make medical decisions in brain metastasis and other metastatic cancers2162-327910.1002/brb3.2303https://doaj.org/article/3a448e66da164c43831ad3380f57fd9a2021-11-01T00:00:00Zhttps://doi.org/10.1002/brb3.2303https://doaj.org/toc/2162-3279Abstract Objective To evaluate the ability of persons with metastatic cancer to self‐assess their medical decision‐making capacity (MDC). To investigate this, we compared an objective measure of MDC with self‐ratings and evaluated predictors of agreement. Methods Data were obtained from a cross‐sectional study of metastatic cancer patients at a large academic medical center. Across all standards of MDC, sensitivity, specificity, and reliability using Gwet's AC1 statistic were calculated using the objective measure as the gold standard. Logistic regression was used to evaluate predictors of agreement between the measures across all MDC standards. Results In those with brain metastases, high sensitivity (greater than 0.7), but low specificity was observed for all standards. Poor reliability was observed across all standards. Higher age resulted in higher odds of disagreement for Standard 3 (appreciation) (OR: 1.07, 95% CI: 1.00, 1.15) and Standard 4 (reasoning) (OR: 1.05, 95% CI: 1.00, 1.10). For Standard 3, chemotherapy use and brain metastases compared to other metastases resulted in higher odds of disagreement (Chemotherapy: OR: 5.62, 95% CI: 1.37, 23.09, Brain Metastases: OR: 5.93, 95% CI: 1.28, 27.55). For Standard 5 (understanding), no predictors were associated with disagreement. Conclusions For less cognitively complex standards (e.g., appreciation), self‐report may be more valid and reliable than more cognitively complex standards (e.g., reasoning or understanding). However, overall, MDC self‐report in the current sample is suboptimal. Thus, the need for detailed assessment of MDC, especially when patients are older or used chemotherapy, is indicated. Other studies should be conducted to assess MDC agreement longitudinally.Mackenzie E. FowlerDario A. MarottaRichard E. KennedyAdam GersteneckerMeredith GammonKristen TriebelWileyarticlebrain metastasismedical decision‐making capacitymetastatic cancerpredictorsNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571ENBrain and Behavior, Vol 11, Iss 11, Pp n/a-n/a (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
brain metastasis medical decision‐making capacity metastatic cancer predictors Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 |
spellingShingle |
brain metastasis medical decision‐making capacity metastatic cancer predictors Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Mackenzie E. Fowler Dario A. Marotta Richard E. Kennedy Adam Gerstenecker Meredith Gammon Kristen Triebel Reliability of self‐report versus the capacity to consent to treatment instrument to make medical decisions in brain metastasis and other metastatic cancers |
description |
Abstract Objective To evaluate the ability of persons with metastatic cancer to self‐assess their medical decision‐making capacity (MDC). To investigate this, we compared an objective measure of MDC with self‐ratings and evaluated predictors of agreement. Methods Data were obtained from a cross‐sectional study of metastatic cancer patients at a large academic medical center. Across all standards of MDC, sensitivity, specificity, and reliability using Gwet's AC1 statistic were calculated using the objective measure as the gold standard. Logistic regression was used to evaluate predictors of agreement between the measures across all MDC standards. Results In those with brain metastases, high sensitivity (greater than 0.7), but low specificity was observed for all standards. Poor reliability was observed across all standards. Higher age resulted in higher odds of disagreement for Standard 3 (appreciation) (OR: 1.07, 95% CI: 1.00, 1.15) and Standard 4 (reasoning) (OR: 1.05, 95% CI: 1.00, 1.10). For Standard 3, chemotherapy use and brain metastases compared to other metastases resulted in higher odds of disagreement (Chemotherapy: OR: 5.62, 95% CI: 1.37, 23.09, Brain Metastases: OR: 5.93, 95% CI: 1.28, 27.55). For Standard 5 (understanding), no predictors were associated with disagreement. Conclusions For less cognitively complex standards (e.g., appreciation), self‐report may be more valid and reliable than more cognitively complex standards (e.g., reasoning or understanding). However, overall, MDC self‐report in the current sample is suboptimal. Thus, the need for detailed assessment of MDC, especially when patients are older or used chemotherapy, is indicated. Other studies should be conducted to assess MDC agreement longitudinally. |
format |
article |
author |
Mackenzie E. Fowler Dario A. Marotta Richard E. Kennedy Adam Gerstenecker Meredith Gammon Kristen Triebel |
author_facet |
Mackenzie E. Fowler Dario A. Marotta Richard E. Kennedy Adam Gerstenecker Meredith Gammon Kristen Triebel |
author_sort |
Mackenzie E. Fowler |
title |
Reliability of self‐report versus the capacity to consent to treatment instrument to make medical decisions in brain metastasis and other metastatic cancers |
title_short |
Reliability of self‐report versus the capacity to consent to treatment instrument to make medical decisions in brain metastasis and other metastatic cancers |
title_full |
Reliability of self‐report versus the capacity to consent to treatment instrument to make medical decisions in brain metastasis and other metastatic cancers |
title_fullStr |
Reliability of self‐report versus the capacity to consent to treatment instrument to make medical decisions in brain metastasis and other metastatic cancers |
title_full_unstemmed |
Reliability of self‐report versus the capacity to consent to treatment instrument to make medical decisions in brain metastasis and other metastatic cancers |
title_sort |
reliability of self‐report versus the capacity to consent to treatment instrument to make medical decisions in brain metastasis and other metastatic cancers |
publisher |
Wiley |
publishDate |
2021 |
url |
https://doaj.org/article/3a448e66da164c43831ad3380f57fd9a |
work_keys_str_mv |
AT mackenzieefowler reliabilityofselfreportversusthecapacitytoconsenttotreatmentinstrumenttomakemedicaldecisionsinbrainmetastasisandothermetastaticcancers AT darioamarotta reliabilityofselfreportversusthecapacitytoconsenttotreatmentinstrumenttomakemedicaldecisionsinbrainmetastasisandothermetastaticcancers AT richardekennedy reliabilityofselfreportversusthecapacitytoconsenttotreatmentinstrumenttomakemedicaldecisionsinbrainmetastasisandothermetastaticcancers AT adamgerstenecker reliabilityofselfreportversusthecapacitytoconsenttotreatmentinstrumenttomakemedicaldecisionsinbrainmetastasisandothermetastaticcancers AT meredithgammon reliabilityofselfreportversusthecapacitytoconsenttotreatmentinstrumenttomakemedicaldecisionsinbrainmetastasisandothermetastaticcancers AT kristentriebel reliabilityofselfreportversusthecapacitytoconsenttotreatmentinstrumenttomakemedicaldecisionsinbrainmetastasisandothermetastaticcancers |
_version_ |
1718414156111020032 |